Here, we present the cryo-EM structure of the light-sensitive GPCR rhodopsin in complex with 32 heterotrimeric Gi. In contrast to all reported structures, our density map reveals the receptor 33 C-terminal tail bound to the Gβ subunit of the G protein heterotrimer. This observation provides 34 a structural foundation for the role of the C-terminal tail in GPCR signaling, and of Gβ as 35 scaffold for recruiting Gα subunits and GRKs. By comparing all available complex structures, 36
proteins, but also G protein-receptor kinases (GRKs) and arrestins. The recent surge in the 27 number of structures of GPCR-G protein complexes has expanded our understanding of G 28 protein recognition and GPCR-mediated signal transduction. However, many aspects of these 29 mechanisms, including the existence of transient interactions with transducers, have remained 30
elusive. 31
Here, we present the cryo-EM structure of the light-sensitive GPCR rhodopsin in complex with 32 heterotrimeric Gi. In contrast to all reported structures, our density map reveals the receptor 33 C-terminal tail bound to the Gβ subunit of the G protein heterotrimer. This observation provides 34 a structural foundation for the role of the C-terminal tail in GPCR signaling, and of Gβ as 35 scaffold for recruiting Gα subunits and GRKs. By comparing all available complex structures, 36
we found a small set of common anchoring points that are G protein-subtype specific. Taken 37 together, our structure and analysis provide new structural basis for the molecular events of 38 the GPCR signaling pathway .  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64 Introduction 70 G protein-coupled receptors (GPCRs) are the most diverse class of integral membrane 71 proteins with almost 800 members in humans. GPCRs are activated by a great diversity of 72 extracellular stimuli including photons, neurotransmitters, ions, proteins, and hormones 73 (Glukhova et al., 2018) . Upon activation, GPCRs couple to intracellular transducers, including 74 four subtypes of G proteins (Gαs, Gαi/o, Gαq/11, Gα12/13) (Milligan & Kostenis, 2006) , seven 75 subtypes of GPCR kinases (GRKs) (Gurevich, Tesmer, Mushegian, & Gurevich, 2012) , and 76 four subtypes of arrestins (Smith & Rajagopal, 2016) (Figure 1A) , among many other partners 77 (Magalhaes, Dunn, & Ferguson, 2012 Freedman, & Lefkowitz, 1998) and binding of arrestin (Goodman Jr et al., 1996) . Despite this 107 biochemical evidence, a direct interaction between rhodopsin and Gβγ could not be observed 108 in the existing complex (Kang et al., 2018) . 109
Here, we present the cryo-EM structure of bovine rhodopsin in complex with a heterotrimeric 110
Gi. Overall, our structure agrees well with a currently published structures (Kang et Figure 3 ), we observed that the density corresponding to Gα is heterogenous (Suppl. Figure  133 4), particularly at flexible regions such as the α-helical (AH) domain. The AH domain was then 134
excluded by using a soft mask during refinement, resulting in a map with a nominal global 135 resolution of 4.38 Å (Suppl. Figure 3D , E). The EM map was used to build a model of the 136 complex (Suppl. Figure 5) . 137
138
Architecture of the rhodopsin-G protein complex 139
The structure of rhodopsin-Gi-Fab16 reveals the features observed in previously reported 140 GPCR-G protein complexes (Figure 1B , C; Suppl. Figure 6A ). In particular, our cryo-EM 141 structure is in excellent agreement with the crystal structure of the same rhodopsin mutant 142 bound to a mini-Go protein (Tsai et al., 2018) , with a nearly identical orientation of the C-143 terminal α5 helix (Suppl. Figure 6B ), which contacts transmembrane helices (TM) 2, 3, 5-7 144 and the TM7/H8 turn of the receptor (Suppl. Figure 5B , and Suppl. 
Interaction between the C-terminal tail of rhodopsin and Gβ 164
The EM map reveals a density on the Gβ subunit as continuation of H8 of the receptor ( Figure  165 2A), which corresponds to the C-tail of rhodopsin. This feature does not exist in any other 166 GPCR-G protein complex, including the human rhodopsin-Gi complex bound to Fab_G50 167 (Kang et al., 2018) . We modeled half of the C-tail of rhodopsin (12 out of 25 residues; 324-168 335) into this density as a continuous stretched peptide with residues G324, P327 and G329 169 serving as flexible hinges ( Figure 2B ). This allows us to compare the structure of this region 170 in three signaling states of the receptor: inactive (Okada et al., 2004) , G protein-bound (this 171 structure), and arrestin-bound (Zhou et al., 2017) ( Figure 2B ). In the inactive state, the C-tail 172 folds around the cytoplasmic side of rhodopsin, although this is likely due to crystal packing 173 as this region is intrinsically disordered in the absence of a binding partner (Jaakola, Prilusky, 174
Sussman, & Goldman, 2005; Venkatakrishnan et al., 2014). In our G protein complex, the C-175 tail stretches over the cleft between Gα and Gβ, interacting with both subunits ( Figure 2C) . In 176 the rhodopsin-arrestin complex part of the proximal segment of the C-terminus (residues 325-177 329) is not resolved, but the distal part could be modeled up to S343, eight residues longer 178 than in our G protein complex and including two phosphorylated sites. In the presence of 179 arrestin, the C-tail stretches further, with residues K339-T342 forming a short β-strand 180
antiparallel to the N-terminal β-strand of arrestin ( Figure 
200

Comparison of the GPCR-G protein binding interface 201
As in the other existing GPCR-G protein complex structures, the C-terminal α5 helix of Gα 202 forms the major contact interface to rhodopsin. We aligned the structures of available complexes using the Cα atoms of H5.11-26. This 207 alignment reduces apparent differences in the binding poses and provides the "viewpoint of 208 the G protein" (Figure 3A) . We compiled an exhaustive list of the residue-residue contacts 209 between the receptor and the α5 helix in all the available GPCR/G protein complexes, and 210 observed that the main contacts to the α5 helix are formed by TM5 and TM6, followed by TM3 211 and TM7/8 ( Figure 3B , Suppl. Besides the canonical interaction with the α5 helix, our complex shows that ICL2 and ICL3 of 221 the receptor are at contact distance to Gi (Suppl. Figure 7A) . In all analyzed structures, we 222 found that ICL2 lies near αN/β1 and β2/β3 of Gα, while ICL3 is close to α4/β6 (Suppl. Figure  223 7 and Suppl. Figure 8) . Interestingly, ICL2 folds into an α-helical structure in all the class A 224 receptors except rhodopsin (Suppl. Figure 9) . 225 ICL2 does not contribute to binding Gα in the structures of 5HT1B-mini-Go and A1AR-Gi. 226 Nevertheless, the contact between Gα and ICL2 seems to discriminate between class A 227 GPCRs -which interact via the αN/β1 loop-and class B GPCRs -which instead the region 228 around β1 and β2/β3 (Suppl. Fig. 8 ) 229 230 ICL3, one of the most diverse regions in GPCRs, is often not completely resolved in the 231 available structures (Suppl. Fig. 7D ), either because it is too flexible or because it has been 232 engineered to facilitate structural determination (Munk et al., 2019 
251
The residues highlighted, and their respective binding site to the receptor, are conserved among all Gi, 252 and Gs, complexes analyzed. All contacts retrieved from this analysis are reported in Suppl. In this work, we present the cryo-EM structure of the signaling complex between bovine 265 rhodopsin and a Gi protein heterotrimer, stabilized using an antibody Fab fragment (Fab16) 266 . Overall, this structure agrees very well with existing complexes. In 267 particular, we found that the binding mode of the G protein Ras domain -including the key C-268 terminal α5 helix-is virtually identical to our previously reported X-ray structure of the same 269 receptor bound to a mini-Go protein (Tsai et al., 2018) (Suppl. Fig. 6B ). 270
However, our EM map shows a density on the Gβ subunit that extends from H8 of the receptor, 271
constituting the proximal segment of the C-terminus (residues G324 to T335) (Figure 2) . One 272 explanation of why the C-tail is observed in our density map and not in other structures may 273 rely on the nature of the components used to reconstitute the reported GPCR complexes 274 (Suppl. Table 4 ). Among those, a meaningful comparison may be done with the μ-opioid 275 receptor complex , which is bound to a shorter version of our antibody 276
Fab16, but in which the C-terminus of the receptor was partially truncated. In the human 277 rhodopsin complex (Kang et al., 2018) , which contains the full length C-tail, a recombinant 278
Gβγ was used. Thus, our bovine rhodopsin complex contains the unique combination of a full-279 length C-tail, Gβγ purified from bovine rod outer segments, and Fab16 that may have 280 contributed to trap the transient interaction of the intrinsically disordered C-tail to Gβ. 1998) and binding of arrestin (Goodman Jr et al., 1996) . Interestingly, HEK cells lacking 292 functional Gα subunits (but retaining the native Gβγ) are still able to recruit arrestin, although 293 they fail to activate ERK and whole-cell responses (Grundmann et al., 2018) . 294
Our findings provide a structural explanation for these roles of Gβγ in GPCR-mediated 295 signaling. We suggest that the observed interaction between the central part of the receptor 296 C-terminus and Gβγ is involved in localizing the G protein heterotrimer to the active receptor 297 first. Fig. 7A ). In particular, we found that ICL2 is at contact 317 distance to the αN helix, the αN/β1 and the β2/β3 Gα in most structures (Suppl . Fig. 7 , Suppl. 318 Fig. 8, and Suppl. Fig. 9 ). While ICL2 contributes to the binding interface, there are no 319 apparent conserved contacts among complexes (Suppl. Fig. 8) human Gαi subunit (Gαi1) with an N-terminal TEV protease-cleavable deca-histidine tag was 343 expressed and purified as described . The transducin heterotrimer was 344 isolated from the rod outer segment of bovine retina and Gβ1γ1 was separated from Gαt with 345
Blue Sepharose 6 Fast Flow (GE Healthcare) as described (Maeda et al., 2014) . The 346 Gαi1β1γ1 heterotrimer (Gi) was prepared by mixing equimolar amounts of Gαi1 with or without 347 10xHis-tag and Gβ1γ1 and incubated at 4°C for 1 hour shortly before use for rhodopsin-Gi 348 complex formation on the 1D4 immunoaffinity column. 349 350
Fab16 production 351
The monoclonal mouse antibody IgG16 was generated as described . 352
Large scale production of IgG16 was performed using adherent hybridoma cell culture grown 353 in DMEM medium supplemented with 10% ultra-low IgG fetal bovine serum (FBS) (Gibco, 354 #16250078) and 25 U/ml of mouse interleukin-6 (Invitrogen, #PMC0064) at 37°C and 5% CO2.
355
Antibody expression was increased by stepwise dilution of FBS concentration down to 2%.
356
After incubation for 10-14 days, ~500-ml cell suspension containing the secreted IgG was 357
clarified by centrifugation and subsequent filtration through a 0.45 µm HAWP membrane 358 (Merck Millipore). The filtrate was mixed with an equal volume of binding buffer (20 mM  359 Na2HPO4/NaH2PO4, pH 7.0) and loaded to a 1-ml HiTrap Protein G Sepharose FF column 360 (GE Healthcare). The column was washed with binding buffer until the UV280 absorbance 361 dropped to a stable baseline, and IgG was eluted with 0.1 M glycine-HCl (pH 2.7). Fractions 362 were immediately neutralized with 1 M Tris-HCl (pH 9.6). Fractions containing IgG16 were 363 combined and dialyzed against 20 mM Na2HPO4/NaH2PO4 (pH 7.0), 1.5 mM NaN3 using a 364 slide-A-lyzer dialysis cassette (12-14 kDa MWCO, Thermo Scientific) at 4 °C for 15 h. The 365 dialysate was collected and mixed with the immobilized papain resin (0.05 ml resin for 1 mg 366 IgG) (Thermo Scientific, #20341). Papain was activated by the addition of L-cysteine and 367
EDTA to a final concentration of 20 mM and 10 mM respectively. IgG was digested overnight 368 at 37°C with gentle mixing. Afterwards the immobilized papain resin was removed and the 369 digested fraction was mixed with Protein A Sepharose (0.2 ml resin for 1 mg digested IgG, GE 370
Healthcare, #17078001) for 1 hour at RT. Resins were washed with two column volumes (CV) 371 of wash buffer 10 mM Tris (pH 7.5), 2.5 M NaCl. The flow-through and washing fractions 372 containing Fab16 were collected and dialyzed against PBS supplemented with 1.5 mM NaN3 373 using a slide-A-lyzer dialysis cassette (12-14 kDa MWCO) at 4 °C. The dialysate was collected 374 and concentrated with a VivaSpin 20 concentrator (10 kDa MWCO, Sartorius) to 375 approximately 1.1 mg/ml. Glycerol was supplemented to the concentrated Fab16 at a final 376 concentration of 10 %, and protein was flash frozen in liquid nitrogen and stored at -20 °C until 377 use for formation of the rhodopsin-Gi-Fab16 complex. 378 379
Fab16 crystallization and structure determination 380
For its crystallization, Fab16 was further purified by SEC on a Superdex 200 Increase 10/300 381 GL column (GE Healthcare) equilibrated in buffer 10 mM Tris (pH 7.5), 50 mM NaCl. Fractions 382 containing pure Fab16 were collected and concentrated to approximately 14 mg/ml using a 383
VivaSpin 4 concentrator (10 kDa MWCO, Sartorius). Fab16 was crystallized by vapor diffusion 384 at 4 °C by dispensing 200 nl of protein and 200 nl of crystallization buffer containing 1.5 M 385 malic acid (pH 7.5), 7 % (v/v) LDAO in an MRC 2-well crystallization plate (Swissci) using a 386 mosquito® crystallization robot. Crystals appeared after one day and grew to full size within 4 387 days. Crystals were soaked in the reservoir solution supplemented with 20 % (v/v) PEG 400 388 as a cryo-protectant and flash frozen in liquid nitrogen. The X-ray data was collected at the 389 PXI beam line at the Swiss Light Source (SLS). Bragg peaks were integrated using XDS for 390 individual datasets. XSCALE was used to scale and combine six datasets, and the pooled 391 reflection list was further analyzed using the STARANISO server (Global Phasing Ltd. id 2AAB without the CDR regions were used for molecular replacement using the program 397
Phaser-MR in the Phenix suite. The model was built automatically using the Phenix AutoBuild, 398 and the coordinates were manually adjusted using the visualization program Coot. The 399 structure was refined using the phenix.refine to 1.90 Å (Suppl. Table 4 Washed resins were resuspended in 1 CV of buffer A and mixed with 10xHis-tagged Gi 419 heterotrimer at the ratio of 2 mg Gi per ml resin with the presence of 25 mU/ml apyrase (New 420 England Biolabs). The resuspended resin/Gi mixture was subjected to irradiation with 495-nm 421 long-passed filter for 10-15 minutes to induce activation of rhodopsin and G protein binding, 422
followed by a 30-min incubation in the dark to allow full hydrolysis of nucleotide by apyrase. 423
Resins were washed with 8 CV of buffer A to remove unbounded Gi heterotrimer. rhodopsin-424
Gi complex was eluted trice in batch with 1.5 CV of buffer containing 20 mM HEPES (pH 7.5), 425 150 mM NaCl, 1 mM MgCl2, 0.02 % LMNG, 80 µM 1D4 peptide (TETSQVAPA) for at least 2-426 hour incubation each time. Elution fractions were combined and incubated for at least 2-hour 427 with Ni-NTA resins (0.5-2 ml), washed with 6 CV of 20 mM HEPES (pH 7.5), 150 mM NaCl, 428 50 mM imidazole, 0.01 % LMNG to remove free rhodopsin. Rhodopsin-Gi was eluted five 429 times with 1 CV of 20 mM HEPES (pH 7.5), 150 mM NaCl, 350 mM imidazole, 0.01 % LMNG. 430
Elution fractions were immediately concentrated using an Amicon Ultra concentrator (MWCO 431 100 kDa) with simultaneous buffer exchange to 20 mM HEPES (pH 7.5), 150 mM NaCl, 0.01 432 % LMNG. Rhodopsin-Gi was mixed with molar excess (1:1.4) of Fab16 and incubated for at 433 least 1 h. The mixture of rhodopsin-Gi and Fab16 was concentrated using an Amicon Ultra 434 concentrator (MWCO 30 kDa) and loaded to a Superdex 200 Increase 10/300 GL column for 435 SEC with detergent-free buffer containing 20 mM HEPES (pH 7.5), 150 mM NaCl. Protein 436 quality of each fraction was evaluated by UV-VIS measurement and SDS-PAGE . Fractions  437 showing OD280/OD380 = ~ 5.9 (ratio between 280 and 380 nm) was chosen for cryo-EM studies. 438
For preparation of rhodopsin-Gi complex, purified rhodopsin and 10xHis-tag-free Gi 439 heterotrimer were mixed in a test tube in equimolar ratio with the presence of 25 mU/ml of 440 apyrase and incubated for 1 hour at 4°C. The initial models of rhodopsin and the Ras-like domain of Gαi protein were adapted from the 466 structure of rhodopsin-mini-Go complex (PDB id: 6FUF). The initial model of Gβγ was obtained 467 from the crystal structure of guanosine 5'-diphosphate-bound transducin (PDB id: 1GOT). The 468 models were docked into the 3D map as rigid bodies in Chimera (Pettersen et al., 2004) . The 469 coordinates of the structure were manually adjusted and the C-terminus of rhodopsin was built 470 in Coot (Emsley & Cowtan, 2004), which was used to visualize the EM map and the models. 471
The models were refined using the phenix.real_space_refine in the Phenix suite (Adams et  472 al., 2010). 473
474
Comparison and analysis of structures 475
Structural models were downloaded from the Protein Data Bank. For comparing structures of 476 the GPCR-G protein complexes, the residue-residue contacts within 4 Å were first identified 477 using PyMOL (The PyMOL Molecular Graphics System, Version 2.0 Schrödinger, LLC). 478 479
Figure preparation 480
Figures were prepared using ChimeraX (Goddard et al., 2018) and PyMOL (The PyMOL  481 Molecular Graphics System, Version 2.0 Schrödinger, LLC). 482 483
